ClinicalTrials.gg
RecruitingNCT07379723Updated Jan 30, 2026

Brief Intervention for FCD: A Feasibility Study

An interventional study of Brief psychological intervention including attention training in Functional Cognitive Disorder, sponsored by King's College Hospital NHS Trust. Recruiting at 1 site in United Kingdom. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-01-30.

Sponsored by King's College Hospital NHS Trust · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Mar 2026, 8 months ago, but the record still lists the study as recruiting.
  • Started Nov 2025; still recruiting 1 year later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 138 studies in Cognitive Dysfunction with a site in United Kingdom — 37 open to participants now, 54 under way, 7 of them phase 3. Cognitive Dysfunction · United Kingdom.

Planned enrollment
69th of 89
30 · median 70
Started
2025
with 16 others
No phase
51 of 138
15 open now
Primary completion
2026-03
later than 17 of 53 live
Registered
131st of 138
by date

Among the 138 studies in Cognitive Dysfunction with a site in United Kingdom, this one is the 69th largest by planned enrollment of the 89 interventional ones that give a count, is one of 17 that started in 2025, is one of 51 with no phase, reaches primary completion later than 17 of the 53 other live ones, and was the 131st registered.

Cognitive Dysfunction

3,885 studies on the registry are indexed under Cognitive Dysfunction; 1,123 are open to participants now.

Browse Cognitive Dysfunction studies →

Open to participants now

37 of the 138 studies in Cognitive Dysfunction with a site in United Kingdom are open now. Recruiting first, the newest first:

31 more — sign in →

All 37 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 751 Cognitive Dysfunction studies recruiting now, 361 (48%) set no upper age limit and 144 (19%) stop at 75 or younger; 46 take children under 18; 260 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 138 studies in Cognitive Dysfunction with a site in United Kingdom, or all of them as a file.
02

Study summary

The goal of this study is to learn if a single session intervention for people with Functional Cognitive Disorder (FCD) is feasible and acceptable. The main questions it aims to answer are:

What is the impact of a single session intervention on FCD symptoms, functional impairment, and quality of life in people with FCD?

What is the feasibility and acceptability of piloting a single session intervention for people with FCD.

Participants will:

  • Complete questionnaires about cognitive concerns, anxiety, depression, functional impairment and quality of life
  • Visit the clinic for a single session intervention including practicing the Attention Training Technique (ATT)
  • Complete 2 telephone calls with a researcher to discuss their use of the intervention and to complete the same questionnaires from their clinic visit, and a questionnaire about their experience of the study and intervention.
03

Conditions studied

  • Functional Cognitive Disorder

Keywords

  • Functional Cognitive Disorder
  • Brief Interventions
  • Feasibility
  • Pilot
  • Attention Training
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 65 or below
  • Meet criteria for diagnosis of FCD (criteria include normal MRI results with no neurological diagnosis, and symptoms that are not explained by any other medical condition, performance at routine pre-baseline neuropsychological assessment within the service)
  • Not taking part in any other intervention study or trial

Exclusion criteria

Exclusion Criteria:

  • Aged above 65 years
  • Lack capacity to consent
  • MRI results not in normal range
  • Neurological diagnosis
  • Indication of severe low mood or depression (from clinical interview, routine measures)
  • Taking part in any other intervention study or trial
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Intervention

    Behavioral: Brief psychological intervention including attention training

Interventions

  • BehavioralBrief psychological intervention including attention training

    Brief psychological intervention including attention training

06

What researchers measure

Primary outcomes

  1. Participant recruitment, feasibility and retention from baseline to follow-up

    • Number of participants recruited and retention rate (number and percentage of participants completing post-intervention measures) will be recorded.

    Time frame: From enrollment to follow-up 6 weeks post-intervention.

Secondary outcomes

  1. Acceptability of the study intervention at follow-up

    • At follow-up, participants will complete a questionnaire to collect information on acceptability of the study and intervention (Theoretical framework of acceptability \[TFA\] questionnaire; Sekhon et al., 2022).

    Time frame: Post-intervention follow-up at 6 weeks.

  2. Change in symptoms of depression from enrolment to post-intervention follow-up

    Participants will complete questionnaire at enrolment and at follow-up post-intervention: • Patient Health Questionnaire 9 (PHQ-9) (Kroenke et al., 2001)

    Time frame: At enrolment and at follow-up 6 weeks post-intervention

  3. Change in symptoms of anxiety from enrolment to post-intervention follow-up

    Participants will complete questionnaire at enrolment and at follow-up post-intervention: • Generalised Anxiety Disorder 7 questionnaire (GAD- 7) (Spitzer et al., 2006)

    Time frame: At enrolment and at follow-up 6 weeks post-intervention

  4. Change in functional impairment from enrolment to post-intervention follow-up

    Participants will complete questionnaire at enrolment and at follow-up post-intervention: • Work and Social Adjustment Scale (WSAS) (Mundt et al., 2002)

    Time frame: At enrolment and at follow-up 6 weeks post-intervention

  5. Change in quality of life from enrolment to post-intervention follow-up

    Participants will complete questionnaire at enrolment and at follow-up post-intervention: • EuroQol 5-Dimension 5-Level (EQ-5D-5L)(Herdman et al., 2011)

    Time frame: At enrolment and at follow-up 6 weeks post-intervention

  6. Change in self-reported cognitive symptoms from enrolment to post-intervention follow-up

    Participants will complete questionnaire at enrolment and at follow-up post-intervention: • The Cognitive Failures Questionnaire 2.0(Goodhew \& Edwards, 2024).

    Time frame: At enrolment and at follow-up 6 weeks post-intervention

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2025 (actual). Primary completion is estimated for Mar 2026, 4 months after the start.

Of 1,453 non-industry interventional studies with no phase under Cognitive Dysfunction, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 51. This study's planned 4 months is below that.

Counting every sponsor, half of 1,522 studies reached it within 27 months; a quarter within 12 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 14, 2026
First posted
Jan 30, 2026
StartActual
Nov 11, 2025
Primary completionEst.
Mar 13, 2026
CompletionEst.
May 1, 2026
Last update
Jan 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07379723
Responsible party
Sponsor
First posted
Jan 30, 2026
Start date
Nov 11, 2025
Primary completion
Mar 13, 2026 (estimated)
Completion
May 1, 2026 (estimated)
Last update
Jan 30, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion